Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021945
Filing Date
2025-11-12
Accepted
2025-11-12 16:31:08
Documents
77
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1064986
2 EX-31.1 ex31-1.htm EX-31.1 12397
3 EX-31.2 ex31-2.htm EX-31.2 12402
4 EX-32.1 ex32-1.htm EX-32.1 7802
5 EX-32.2 ex32-2.htm EX-32.2 7645
  Complete submission text file 0001493152-25-021945.txt   5868050

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfri-20250930.xsd EX-101.SCH 47867
7 XBRL CALCULATION FILE bfri-20250930_cal.xml EX-101.CAL 72631
8 XBRL DEFINITION FILE bfri-20250930_def.xml EX-101.DEF 261622
9 XBRL LABEL FILE bfri-20250930_lab.xml EX-101.LAB 384213
10 XBRL PRESENTATION FILE bfri-20250930_pre.xml EX-101.PRE 332311
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 727719
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 251473458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)